REGULAR COURSE
The highly interactive classes with SsBox, SsMnemonics and 24/7 Mentor Support via telegram group will fulfill all of your needs. Your mentor (Dr. Sumanta Kumer Saha) is always ready for personal counseling. You will be taken care by SsAcademy Full Team till your Exam.
For any Information Feel Free to Contact us
Why Should I Join This Course?
Highly Interactive Classes with a discussion of all Hot, Important & Difficult uugfg. You will get all Recent Guidelines, Exam Focused Notes & Discussions, and Mock Test after the completion of Each Chapter. A private “My Mentor Telegram Group” is always ready for academic discussion. We assure your highest Success.
It’s a complete course of 10+ Lectures, 12+ Exams with all the essential study materials.
A Complete Lecture Notes (Printed Copy) covering all the important topics will be provided on each system.
Full Online Access to revise the recorded classes, online mock exams , download books, question bank and many more.
It’s one of the best course in world or MRCP Part-1 Exam Preparation.
You will get the necessary matarials to be prepared effectively for the exam.
A Complete Mock Test Series Package (System Test = 10 and Mock Test = 2)
The total duration of this course is 3 months. The following facilities will be available in the course.
A single class is divided into three seasons. The following seasons are given below:
Our mission is to provide the best quality medical education with a very convenient fees structure for every candidate.
| CATEGORY | WEEKS | CLASSES | EXAMS |
| Block-01 | |||
| 01. Rheumatology + Orthopedics | 1 | 1 | 1 |
| 02. Cardiology + Critical Care + Emergency | 1 | 1 | 1 |
| 03. Neurology + Psychiatry + ENT | 1 | 1 | 1 |
| Block-02 | |||
| 04. Endocrinology + Epidemiology + Ethics | 1 | 1 | 1 |
| 05. Gastroenterology + General Surgery | 1 | 1 | 1 |
| 06. Nephrology + Genitourinary + Urology | 1 | 1 | 1 |
| Block-03 | |||
| 07. Respiratory + Anatomy + OBS & GYNE | 1 | 1 | 1 |
| 08. Infectious Diseases + Vascular Surgery | 1 | 1 | 1 |
| 09. Pharmacology + Haematology + Dermatology + Palliative Care | 1 | 1 | 1 |
| Block-04 | |||
| 10. Geriatrics + Genetics + Paediatrics | 1 | 1 | 1 |
| 11. Mock – 01 | – | – | 1 |
| 12. Mock – 02 | – | – | 1 |
| TOTAL | 10 | 10 | 12 |
Office Phone
+880 17 986 65500
STAY UP TO DATE
Your Mentor Dr. Tamanna Tabassum covers more than 500+ topics within 3 months. This Unique Course is designed with SsBox, SsMnemonic, and Ss Guidelines which will help to memorize and get to understand all the topics properly.
| SL | Content |
|---|---|
| 1 | Paget’s Disease of Bone |
| 2 | Autoantibodies & Disease Associations |
| 3 | Rheumatoid Arthritis: Antibodies |
| 4 | ANCA |
| 5 | Extractable Nuclear Antigens |
| 6 | RA (Rheumatoid Arthritis) |
| 7 | RA (Rheumatoid Arthritis): Epidemiology |
| 8 | RA (Rheumatoid Arthritis): Diagnosis |
| 9 | RA: Prognostic Features |
| 10 | RA (Rheumatoid Arthritis): Management |
| 11 | Methotrexate |
| 12 | Hydroxychloroquine |
| 13 | Leflunomide |
| 14 | Sulfasalazine |
| 15 | Tumour necrosis factor |
| 16 | RA (Rheumatoid Arthritis): Complications |
| 17 | RA: Respiratory Manifestations |
| 18 | RA: Ocular Manifestations |
| 19 | RA (Rheumatoid Arthritis): X-Ray Changes |
| 20 | RA (Rheumatoid Arthritis): Pregnancy |
| 21 | Cryoglobulinaemia |
| 22 | SJS (Sjogren’s Syndrome) |
| 23 | SLE |
| 24 | DIL-Drug-Induced Lupus |
| 25 | Systemic Lupus Erythematosus |
| 26 | Systemic Lupus Erythematosus: Features |
| 27 | Systemic Lupus Erythematosus: Investigations |
| 28 | Still’s disease in adults |
| 29 | Raynaud’s Phenomenon |
| 30 | SLE: Pregnancy |
| 31 | Antiphospholipid Syndrome |
| 32 | Discoid lupus erythematous |
| 33 | SSC (Systemic Sclerosis) |
| 34 | Crystal Arthropathy |
| 35 | Septic arthritis in adults |
| 36 | Gout: Features |
| 37 | Gout: Predisposing Factors |
| 38 | Lesch-Nyhan Syndrome |
| 39 | Gout: Drug Causes |
| 40 | Gout: Management |
| 41 | Pseudogout |
| 42 | Lower Back Pain |
| 43 | Lower Back Pain: Prolapsed Disc |
| 44 | Lumbar spinal stenosis |
| 45 | Iliopsoas abscess |
| 46 | Seronegative Spondyloarthropathies |
| 47 | Common Features |
| 48 | ReA (Reactive Arthritis)- 1 |
| 49 | ReA (Reactive Arthritis)- 2 |
| 50 | AS (Ankylosing Spondylitis)- Features |
| 51 | AS: Investigation and Management |
| 52 | Azathioprine |
| 53 | Mycophenolate mofetil |
| 54 | PsA (Psoriatic Arthropathy) |
| 55 | BS (Behcets Syndrome) |
| 56 | PMR (Polymyalgia Rheumatica) |
| 57 | PM (Polymyositis) |
| 58 | DM (Dermatomyositis) |
| 59 | Investigations and Management |
| 60 | Osteoarthritis & Osteoporosis |
| 61 | Rickets |
| 62 | Osteomalacia |
| 63 | Vitamin D supplementation |
| 64 | Osteoporosis: Causes |
| 65 | Osteoporosis- Risk Factors |
| 66 | Osteoarthritis: Management |
| 67 | Osteopetrosis |
| 68 | Osteoporosis: DEXA Scan |
| 69 | Osteoporosis: Management |
| 70 | Denosumab |
| 71 | Osteoporosis: Glucocorticoid-Induced |
| 72 | ANCA associated vasculitis |
| 73 | Vasculities |
| 74 | WG/ GPA |
| 75 | PAN (Poly Arteritis Nodosa) |
| 76 | CFS (Chronic Fatigue Syndrome) |
| 77 | Others |
| 78 | Ehler-Danlos syndrome |
| 79 | Osteogenesis imperfect |
| 80 | Mixed Connective Tissue Disease |
| 81 | McArdle’s Disease |
| 82 | Myopathies |
| 83 | Pseudoxanthoma Elasticum |
| 84 | Bisphosphonates |
| 85 | Adhesive Capsulitis |
| 86 | Langerhans cell histiocytosis |
| 87 | Ankle Injury: Ottawa Rules |
| 88 | Avascular Necrosis of the hip |
| 89 | Carpal Tunnel Syndrome |
| 90 | Cubital tunnel syndrome |
| 91 | Dactylitis |
| 92 | Osteomyelitis |
| 93 | De Quervain’s Tenosynovitis |
| 94 | Elbow Pain |
| 95 | Familial Mediterranean Fever |
| 96 | Relapsing polychondritis |
| 97 | Fibromyalgia |
| 98 | Hip Pain in Adults |
| 99 | Meralgia paraesthetica |
| 100 | Lateral Epicondylitis |
| 101 | Rotator Cuff Muscles |
| 102 | Hormone Replacement Therapy |
| 103 | Temporal Arteritis |
| 104 | Summary (Rheumatology) |
| 105 | ECG |
|---|---|
| 106 | Cardiac Action Potential |
| 107 | ECG: Normal Variants |
| 108 | ECG: Coronary Territories |
| 109 | ECG: Axis Deviation |
| 110 | ECG: PR Interval |
| 111 | Complete Heart Block |
| 112 | ECG: Left Bundle Branch Block |
| 113 | ECG: ST Elevation |
| 114 | ECG: ST Depression |
| 115 | ECG: Hypothermia |
| 116 | ECG: Hypokalaemia |
| 117 | Clinical Parameters |
| 118 | Pulses |
| 119 | Heart Sounds |
| 120 | Heart Sounds: S2 |
| 121 | Murmurs |
| 122 | Jugular Venous Pulse |
| 123 | Jugular Venous Pulse |
| 124 | JVP: Cannon Waves |
| 125 | Infective Endocarditis |
| 126 | IE: Modified Duke Criteria |
| 127 | Infective Endocarditis |
| 128 | IE: Prognosis and Management |
| 129 | Infective Endocarditis: Prophylaxis |
| 130 | Vulvular Heart Diseases |
| 131 | Aortic Stenosis |
| 132 | Angiodysplasia |
| 133 | Aortic Regurgitation |
| 134 | Marfan’s Syndrome |
| 135 | Osteogenesis Imperfect |
| 136 | Ehler-Danlos Syndrome |
| 137 | Mitral Stenosis |
| 138 | Rheumatic Fever: Features |
| 139 | MS-Complications & Indications |
| 140 | Mitral Stenosis-Severity |
| 141 | Mitral Valve Prolapse |
| 142 | Prosthetic Heart Valves |
| 143 | Tricuspid Regurgitation |
| 144 | Bicuspid Aortic Valve |
| 145 | Congenital Heart Disease |
| 146 | Congenital Heart Disease: Types |
| 147 | Atrial Septal Defects |
| 148 | Eisenmenger’s Syndrome |
| 149 | Patent Ductus Arteriosus |
| 150 | Down Syndrome: Features |
| 151 | Patent Foramen Ovale |
| 152 | Paradoxical Embolisation |
| 153 | Ventricular Septal Defects |
| 154 | Tetralogy of Fallot |
| 155 | Transposition of The Great Arteries |
| 156 | Ebstein’s Anomaly |
| 157 | Arrhythmias |
| 158 | Investigating Palpitations |
| 159 | Adult Advanced Life Support |
| 160 | Peri-Arrest Rhythms: Tachycardia |
| 161 | Supraventricular Tachycardia |
| 162 | Valsalva Manoeuvre |
| 163 | Broad Complex Tachycardia |
| 164 | Catecholaminergic Polymorphic Ventricular Tachycardia |
| 165 | Multifocal Atrial Tachycardia |
| 166 | Ventricular Tachycardia: Management |
| 167 | Ventricular Tachycardia |
| 168 | Torsades De Pointes |
| 169 | Peri-Arrest Rhythms: Bradycardia |
| 170 | Pacemakers: Temporary |
| 171 | Atrial Fibrillation |
| 172 | Dabigatran |
| 173 | Atrial Flutter |
| 174 | Wolff-Parkinson White |
| 175 | Long QT Syndrome |
| 176 | Implantable Cardiac Defibrillators |
| 177 | ECG: Digoxin |
| 178 | Ischaemic Heart Disease |
| 179 | Cardiac Enzymes and Protein Markers |
| 180 | Coronary Circulation |
| 181 | Angina Pectoris: Drug Management |
| 182 | Syndrome X |
| 183 | Nicorandil |
| 184 | Patients with Suspected Cardiac Chest Pain |
| 185 | Thrombolysis |
| 186 | MI: Secondary Prevention |
| 187 | Acute Coronary Syndrome: Management |
| 188 | ADP Receptor Inhibitors |
| 189 | Acute Coronary Syndrome: Prognostic Factors |
| 190 | Cholesterol Embolisation |
| 191 | Myocardial infarction: complications |
| 192 | Antiplatelets: Summary of Latest Guidance |
| 193 | Percutaneous Coronary Intervention |
| 194 | Peripheral Arterial Disease: Management |
| 195 | Parenteral Anticoagulation |
| 196 | DVLA: Cardiovascular Disorders |
| 197 | Cardiac Catherisation and Oxygen Saturation Levels |
| 198 | Cardiac Myopathy |
| 199 | HOCM: Features |
| 200 | HOCM: Prognostic Factors |
| 201 | HOCM: Management |
| 202 | Dilated Cardiomyopathy |
| 203 | Restrictive Cardiomyopathy |
| 204 | Arrhythmogenic Right Ventricular Cardio |
| 205 | Brugada Syndrome |
| 206 | Myocarditis |
| 207 | Cardiac Failure: Drug Management |
| 208 | Heart Failure: Drug Management |
| 209 | Heart Failure: NYHA Classification |
| 210 | Chronic Heart Failure: Diagnosis |
| 211 | Heart Failure: Non-Drug Management |
| 212 | Pulmonary Capillary Wedge Pressure |
| 213 | Atrial Myxoma |
| 214 | Cardiac Tamponade |
| 215 | Cardiac Tamponade |
| 216 | Acute Pericarditis |
| 217 | Hypertension |
| 218 | Blood Pressure Measurement |
| 219 | Hypertension: Secondary Causes |
| 220 | Hypertension: Diagnosis |
| 221 | Centrally Acting Antihypertensives |
| 222 | Diabetes Mellitus: Hypertension Management |
| 223 | Angiotensin II Receptor Blockers |
| 224 | Hydralazine |
| 225 | Malignant Hypertension |
| 226 | Turner’s Syndrome |
| 227 | Coarctation of The Aorta |
| 228 | Isolated Systolic Hypertension |
| 229 | Hypertension in Pregnancy |
| 230 | Pre-eclampsia |
| 231 | Hypertension: Management |
| 232 | Takayasu’s Arteritis |
| 233 | Aortic Dissection |
| 234 | Aortic Dissection: Investigation & Management |
| 235 | Pulmonary Hypertension |
| 236 | Primary Pulmonary Hypertension |
| 237 | Causes & Classification |
| 238 | Features and Management |
| 239 | Hyperlipidaemia: Xanthomata |
| 240 | Hyperlipidaemia: Management |
| 241 | Cardiac Imaging: Non-Invasive Techniques |
| 242 | Syncope |
| 243 | Familial Hypercholesterolaemia |
| 244 | Hyperlipidaemia: Mechanism of Action |
| 245 | Eclampsia |
| 246 | Exercise: Physiological Changes |
| 247 | Exercise Tolerance Tests |
| 248 | Scoring Systems |
| 249 | Cardio- Vascular Medications |
| 250 | Aspirin |
| 251 | Dipyridamole |
| 252 | Statins |
| 253 | Nicotinic Acid |
| 254 | Adrenoceptor Antagonists |
| 255 | Adrenaline |
| 256 | Angiotensin-Converting Enzyme |
| 257 | Calcium Channel Blockers |
| 258 | Loop Diuretics |
| 259 | Bendroflumethiazide |
| 260 | Spironolactone |
| 261 | Sildenafil |
| 262 | Prescribing in Patients with Heart Failure |
| 263 | Summary (Cardiology) |
| 164 | Shin Lesions |
|---|---|
| 165 | Pyoderma Gangrenosum |
| 166 | Erythema Nodosum |
| 167 | Erythema Multiforme |
| 168 | Stevens-Johnson Syndrome |
| 169 | Toxic Epidermal Necrolysis |
| 170 | Skin Disorders Associated with Pregnancy |
| 171 | Skin Disorders Associated with Thyroid Disease |
| 172 | Erythema Ab Igne |
| 173 | Impetigo |
| 174 | Genital Warts |
| 175 | Cervical Cancer |
| 176 | Pityriasis Versicolor |
| 177 | Alopecia |
| 178 | Alopecia Areata |
| 179 | Psoriasis |
| 180 | Psoriasis: Management |
| 181 | Psoriasis: Guttate |
| 182 | Psoriasis: Exacerbating Factors |
| 183 | Onycholysis |
| 184 | Lichen Planus |
| 185 | Lichen Sclerosus |
| 186 | Skin Disorders Associated with Diabetes |
| 187 | Granuloma Annulare |
| 188 | Acanthosis Nigricans |
| 189 | Koebner Phenomenon |
| 190 | Zinc Deficiency |
| 191 | Systemic Mastocytosis |
| 192 | Hirsutism and Hypertrichosis |
| 193 | Acne Vulgaris |
| 194 | Acne Vulgaris: Management |
| 195 | Retinoids |
| 196 | Acne Rosacea |
| 197 | Eczema: Diagnosis |
| 198 | Eczema Herpeticum |
| 199 | Contact Dermatitis |
| 200 | Nickel Dermatitis |
| 201 | Antihistamines |
| 202 | Pityriasis Rosea |
| 203 | Pemphigus Vulgaris |
| 204 | Bullous Pemphigoid |
| 205 | Porphyria Cutanea Tarda |
| 206 | Photosensitive Skin Disorders |
| 207 | Bullous Disorders |
| 208 | Dermatitis Herpetiformis |
| 209 | Venous Ulceration |
| 210 | Yellow Nail Syndrome |
| 211 | Erythrasma |
| 212 | Actinic Keratoses |
| 213 | Caf-au-lait Spots |
| 214 | Discoid Lupus Erythematous |
| 215 | Livedo Reticularis |
| 216 | Erythroderma |
| 217 | Fungal Nail Infections |
| 218 | Hyperhidrosis |
| 219 | Keloid Scars |
| 220 | Keratoacanthoma |
| 221 | Lentigo Maligna |
| 222 | Leprosy |
| 223 | Malignant Melanoma: Prognostic Factors |
| 224 | Malignant Melanoma |
| 225 | Molluscum Contagiosum |
| 226 | Hereditary Haemorrhagic Telangiectasia |
| 227 | Myxoid Cyst |
| 228 | Otitis Externa |
| 229 | Pellagra |
| 230 | Pompholyx |
| 231 | Scabies |
| 232 | Seborrhoeic Dermatitis in Adults |
| 233 | Skin Disorders Associated with Tuberculosis |
| 234 | Tinea |
| 235 | Eczema: Topical Steroids |
| 236 | Vitiligo |
| 237 | Skin Disorders Associated with Malignancy |
| 238 | Basal Cell Carcinoma |
| 239 | Squamous Cell Carcinoma of the Skin |
| 240 | Pressure Ulcers |
| 241 | Pruritus |
| 242 | Summary (Dermatology) |
| 243 | DM (Diabetes Mellitus) |
|---|---|
| 244 | Diabetes: Pathophysiology |
| 245 | Diabetes Mellitus: A Very Basic Introduction |
| 246 | Diabetes Mellitus: Management of Type 1 |
| 247 | DM (Diabetes Mellitus) (Type 2): Diagnosis |
| 248 | DM (Diabetes Mellitus) (Type 2): Management |
| 249 | DM (Type 2): Nice Algorithm |
| 250 | TDM medications |
| 251 | Prediabetes and Impaired Glucose Regulation |
| 252 | MODY |
| 253 | Metformin |
| 254 | SUN (Sulfonylureas) |
| 255 | Thiazolidinediones |
| 256 | Meglitinides |
| 257 | Acarbose |
| 258 | DM: GLP- and The New Drugs |
| 259 | SGLT- Inhibitors |
| 260 | Diabetes Mellitus: Ramadan |
| 261 | DVLA: Diabetes Mellitus |
| 262 | HbAC (Glycosylated Haemoglobin) |
| 263 | DKA (Diabetic KetoAcidosis) |
| 264 | Alcoholic Ketoacidosis |
| 265 | HHS (Hyperosmolar Hyperglycaemic State) |
| 266 | DN (Diabetic Neuropathy) |
| 267 | Neuropathic Pain |
| 268 | Pregnancy: DM (Diabetes Mellitus) |
| 269 | Diabetic Foot Disease |
| 270 | Hypoglycaemia |
| 271 | Insulinoma |
| 272 | Side-Effects of Common Drugs Diabetes Drugs |
| 273 | DI (Diabetes Insipidus) |
| 274 | DI (Diabetes Insipidus) |
| 275 | Water Deprivation Test |
| 276 | MS (Metabolic Syndrome) |
| 277 | MS (Metabolic Syndrome) |
| 278 | PCOS: Features and Investigation |
| 279 | PCOS: Management |
| 280 | Obesity: Bariatric Surgery |
| 281 | Obesity: Therapeutic Options |
| 282 | Thyroid |
| 283 | Neck Lumps |
| 284 | Thyroid Disorders: A Very Basic Introduction |
| 285 | Hypothyroidism & Hyperthyroidism: Causes |
| 286 | Thyroid Status: Hypothyroidism & Hyperthyroid |
| 287 | Hypothyroidism & Hyperthyroidism: Investigati |
| 288 | SES (Sick Euthyroid Syndrome) |
| 289 | Thyroid Function Tests |
| 290 | Subclinical Hypothyroidism (SCH) |
| 291 | Subclinical Hyperthyroidism |
| 292 | Hypothyroidism: Causes |
| 293 | Hypothyroidism: Features |
| 294 | Hypothyroidism: Management |
| 295 | Skin disorders associated with thyroid dis |
| 296 | Subacute (De Quervain’s) Thyroiditis |
| 297 | Hashimoto’s Thyroiditis |
| 298 | Riedel’s Thyroiditis |
| 299 | Graves’ Disease: Features |
| 300 | Thyroid Eye Disease |
| 301 | Graves’ Disease: Management |
| 302 | Carbimazole |
| 303 | Toxic Multinodular Goiter |
| 304 | Thyroid storm |
| 305 | Thyroid Cancer |
| 306 | Pregnancy: Thyroid Problems |
| 307 | Thyrotoxicosis |
| 308 | Myxedema Coma/Crisis |
| 309 | Pendred’s Syndrome |
| 310 | Parathyroid |
| 311 | Hypercalcaemia: Causes |
| 312 | Hypercalcaemia: management |
| 313 | Primary HyperParathyroidism (PTH?) |
| 314 | Hypoparathyroidism |
| 315 | Hungry bone syndrome |
| 316 | Hypocalcaemia: features |
| 317 | Alkaline phosphatase |
| 318 | Hypocalcaemia: causes and management |
| 319 | PHP (Pseudo-Hypo-Parathyroidism) |
| 320 | MEN (Multiple Endocrine Neoplasia) |
| 321 | Autoimmune Polyendocrinopathy Syndrome |
| 322 | Adrenal Gland |
| 323 | Addison’s Disease |
| 324 | Addison’s Disease: Investigations |
| 325 | Hypokalaemia and Hypertension |
| 326 | Primary Hyperaldosteronism |
| 327 | Bartter’s Syndrome |
| 328 | Liddle’s Syndrome |
| 329 | Gitelman’s Syndrome |
| 330 | Apparent Mineralocorticoid Excess |
| 331 | CS (Cushing’s Syndrome: Causes) |
| 332 | CS (Cushing’s Syndrome: Investigations) |
| 333 | Corticosteroids |
| 334 | Corticosteroids: side-effects |
| 335 | Phaeochromocytoma |
| 336 | Congenital adrenal hyperplasia |
| 337 | Pituitary |
| 338 | PA (Pituitary Adenoma) |
| 339 | Gynaecomastia |
| 340 | Prolactin and Galactorrhoea |
| 341 | Pituitary Tumours |
| 342 | Acromegaly: Features |
| 343 | Acromegaly: Investigations |
| 344 | Acromegaly: Management |
| 345 | Amenorrhoea |
| 346 | Dynamic Pituitary Function Tests |
| 347 | Insulin Stress Test |
| 348 | AIS (Androgen Insensitivity Syndrome) |
| 349 | Hyperlipidaemia |
| 350 | Hyperlipidaemia: Secondary Causes |
| 351 | Hyperlipidaemia: Management |
| 352 | Fibrates |
| 353 | Familial Hypercholesterolaemia |
| 354 | Remnant Hyperlipidaemia |
| 355 | GONADS |
| 356 | PMOF (PreMature Ovarian Failure) |
| 357 | Others |
| 358 | Carcinoid Syndrome |
| 359 | Summary (Endocrinology, DM Medicine) |
| 360 | Cerebellar Syndrome |
|---|---|
| 361 | Nystagmus |
| 362 | ACM (Arnold-Chiari Malformation) |
| 363 | SP (Spastic Para Paresis) |
| 364 | Transverse Myelitis |
| 365 | DCM (Degenerative Cervical Myelopathy) |
| 366 | Cervical Spondylitic Myelopathy |
| 367 | AAJ (Absent Ankle Jerks, Extensor Plantars) |
| 368 | MS (Multiple Sclerosis: Features) |
| 369 | Internuclear Ophthalmoplegia |
| 370 | Multiple Sclerosis: Investigation |
| 371 | Multiple Sclerosis |
| 372 | MS (Multiple Sclerosis: Prognostic Features) |
| 373 | Neuromyelitis Optica |
| 374 | MS (Multiple Sclerosis: Management) |
| 375 | CADASIL |
| 376 | MND (Motor Neuron Disease: Features) |
| 377 | MND (Motor Neuron Disease: Types) |
| 378 | MND (Motor Neuron Disease: Management) |
| 379 | FA (Friedreich’s Ataxia) |
| 380 | Subacute Combined Degeneration of Spinal |
| 381 | Ataxic Telangiectasia |
| 382 | SM (Syringomyelia) |
| 383 | Brown-Sequard Syndrome |
| 384 | Lumbar Spinal Stenosis |
| 385 | Spinal Cord Lesions |
| 386 | ET (Essential Tremor) |
| 387 | Parkinsonism |
| 388 | PD (Parkinson’s Disease: Features) |
| 389 | PD (Parkinson’s Disease: Management) |
| 390 | PSP (Progressive Supranuclear Palsy) |
| 391 | Levodopa |
| 392 | Multiple System Atrophy |
| 393 | Lewy Body Dementia |
| 394 | Neuroleptic Malignant Syndrome |
| 395 | Chorea |
| 396 | Huntington’s Disease |
| 397 | Ptosis DD |
| 398 | Miosis |
| 399 | 3rd NP (Third Nerve Palsy) |
| 400 | HS (Horner’s Syndrome) |
| 401 | FNP (Facial Nerve Palsy) |
| 402 | Facial Nerve- Anatomy |
| 403 | Ramsay Hunt Syndrome |
| 404 | Bell’s Palsy |
| 405 | Vestibular Schwannoma |
| 406 | Rinne’s and Weber’s Test |
| 407 | Otosclerosis |
| 408 | Macroglossia |
| 409 | Trigeminal Neuralgia |
| 410 | PN (Peripheral Neuropathy) |
| 411 | PN: Demyelinating Vs. Axonal) |
| 412 | Paraneoplastic Syndromes Affecting Nervous |
| 413 | Charcot-Marie-Tooth Disease |
| 414 | HSMN |
| 415 | Drugs Causing Peripheral Neuropathy |
| 416 | Autonomic Neuropathy |
| 417 | Neuropathic Pain |
| 418 | Meralgia Paraesthetica |
| 419 | Nerve Conduction Studies |
| 420 | Brachial Neuritis |
| 421 | Brachial Plexus Injuries |
| 422 | CuTS (Cubital Tunnel Syndrome) |
| 423 | Common Peroneal Nerve Lesion |
| 424 | Foot Drop |
| 425 | GBS (Guillain-Barre Syndrome) |
| 426 | GBS (Guillain-Barre Syndrome: Features) |
| 427 | GBS (Guillain-Barre Syndrome: Prognosis) |
| 428 | GBS (Guillain-Barre Syndrome: Management) |
| 429 | Cerebrospinal Fluid: Raised Protein |
| 430 | WE (Wernicke’s Encephalopathy) |
| 431 | Headache Approach |
| 432 | IIH (Idiopathic Intracranial Hypertension) |
| 433 | Intracranial Haemorrhage |
| 434 | Subarachnoid Hemorrhage |
| 435 | Subdural Haemorrhage |
| 436 | Post-Lumbar Puncture Headache |
| 437 | Pituitary Apoplexy |
| 438 | Gross Anatomy |
| 439 | Aphasia |
| 440 | Stroke: Assessment |
| 441 | Stroke by Anatomy |
| 442 | Stroke: Types |
| 443 | TIA (Transient Ischaemic Attack) |
| 444 | Stroke: Management |
| 445 | Stroke Management: Other Issues |
| 446 | Baclofen |
| 447 | Antiplatelet & Anticoagulant Therapy |
| 448 | LMS (Wallenberg’s Syndrome) |
| 449 | Visual Field Defects |
| 450 | Herpes Simplex Encephalitis |
| 451 | Meningitis |
| 452 | Cerebrospinal Fluid: Raised Lymphocytes |
| 453 | Acute Disseminated Encephalomyelitis |
| 454 | ANRE (Anti-NMDA Receptor Encephalitis) |
| 455 | Brain Abscess |
| 456 | NF (Neurofibromatosis) |
| 457 | Tuberous Sclerosis |
| 458 | MD (Myotonic Dystrophy) |
| 459 | FSHMD |
| 460 | MG (Myasthenia Gravis) |
| 461 | Neck lumps |
| 462 | CD (Castleman Disease) |
| 463 | Otitis externa |
| 464 | LEMS (Lambert-Eaton Syndrome) |
| 465 | Dermatomes |
| 466 | Triptans |
| 467 | Medication Overuse Headache |
| 468 | Migraine: Diagnostic Criteria |
| 469 | Migraine |
| 470 | Migraine: Management |
| 471 | Migraine: Pregnancy, Contraception & Other |
| 472 | MBA (Migraine with Brainstem Aura) |
| 473 | Cluster Headache |
| 474 | Intracranial Venous Thrombosis |
| 475 | Hemiballism |
| 476 | Subdural Haemorrhage |
| 477 | Urinary Incontinence |
| 478 | Normal Pressure Hydrocephalus |
| 479 | Epilepsy: Classification |
| 480 | Epilepsy in Children: Syndromes |
| 481 | Epilepsy: Localising Features of Focal Seizu |
| 482 | Status Epilepticus |
| 483 | Epilepsy: Pregnancy and Breast Feeding |
| 484 | Epilepsy: Treatment |
| 485 | DVLA: Neurological Disorders |
| 486 | Phenytoin |
| 487 | Sodium Valproate |
| 488 | Topiramate |
| 489 | Lamotrigine |
| 490 | Vigabatrin |
| 491 | Vertigo |
| 492 | Vestibular Neuronitis |
| 493 | Restless Legs Syndrome |
| 494 | Cataplexy |
| 495 | Narcolepsy |
| 496 | Absence Seizures |
| 497 | Head Injury: NICE Guidance |
| 498 | Head Injury: Types of Traumatic Brain Injury |
| 499 | Head Injury: NICE Guidance On Investigati |
| 500 | Menieres Disease |
| 501 | Benign Paroxysmal Positional Vertigo |
| 502 | Tinnitus |
| 503 | Von Hippel-Lindau Syndrome |
| 504 | Complex Regional Pain Syndrome |
| 505 | TGA (Transient Global Amnesia) |
| 506 | Alzheimer’s Disease: Management |
| 507 | Vascular Dementia |
| 508 | Creutzfeldt-Jakob Disease |
| 509 | Fourth Nerve Palsy |
| 510 | Summary (Neurology) |
| 511 | CSS (Churg-Strauss Syndrome) |
|---|---|
| 512 | Asthma: Diagnosis in Adults |
| 513 | Asthma: Diagnosis |
| 514 | Asthma: Acute Severe |
| 515 | Acute Severe Asthma-Management |
| 516 | Asthma: Occupational |
| 517 | COPD: Causes |
| 518 | Asthma: Stepwise Management in Adults |
| 519 | Asthma: Management in Adults |
| 520 | COPD: Investigation and Diagnosis |
| 521 | Alpha- Antitrypsin Deficiency |
| 522 | COPD: Stable Management |
| 523 | COPD: Long-Term Oxygen Therapy (LTOT) |
| 524 | NIV (Non-Invasive Ventilation) |
| 525 | O- Oxygen Therapy |
| 526 | COPD: Management of Acute Exacerbations |
| 527 | Acute COPD-Management |
| 528 | Pneumothorax |
| 529 | OSAHS |
| 530 | Pneumonia: Community-Acquired |
| 531 | Pneumonia: Prognostic Factors |
| 532 | Pneumonia: Assessment and Management |
| 533 | PE (Pleural Effusion) |
| 534 | Pleural Effusion: Investigation |
| 535 | Mycoplasma Pneumoniae |
| 536 | Legionella |
| 537 | Klebsiella |
| 538 | Psittacosis |
| 539 | HIV: Pneumocystis Jiroveci Pneumonia |
| 540 | Pulmonary Function Tests |
| 541 | Transfer Factor |
| 542 | Lung Fibrosis |
| 543 | Drugs Causing Lung Fibrosis |
| 544 | Asbestos and The Lung |
| 545 | Pulmonary Eosinophilia |
| 546 | Eosinophilic Granulomatosis With Polyangiitis |
| 547 | Silicosis |
| 548 | Extrinsic Allergic Alveolitis (EAA) |
| 549 | Sarcoidosis |
| 550 | Lofgren’s Syndrome |
| 551 | Bilateral Hilar Lymphadenopathy |
| 552 | Sarcoidosis: Investigation |
| 553 | Sarcoidosis: Prognostic Features |
| 554 | Sarcoidosis: Management |
| 555 | Idiopathic Pulmonary Fibrosis |
| 556 | Cryptogenic Organizing Pneumonia |
| 557 | Bronchiectasis: Causes |
| 558 | Bronchiectasis: Management |
| 559 | Cystic Fibrosis: Features |
| 560 | Cystic Fibrosis |
| 561 | Cystic Fibrosis: Management |
| 562 | Allergic Bronchopulmonary Aspergillosis |
| 563 | Aspergilloma |
| 564 | Kartagener’s Syndrome |
| 565 | ARDS |
| 566 | PE (Pulmonary Embolism: Investigation) |
| 567 | Pulmonary Embolism: Management |
| 568 | Pregnancy: DVT/PE Investigation |
| 569 | Lung Cancer: Risk Factors |
| 570 | Lung Cancer: Types |
| 571 | Lung Cancer: Non-Small Cell Management |
| 572 | Lung Cancer: Carcinoid |
| 573 | Lung Cancer: Non-Small Cell |
| 574 | Lung Cancer: Paraneoplastic Features |
| 575 | Lung Cancer: Small Cell |
| 576 | Lung Cancer: Investigation |
| 577 | Lung Cancer: Referral |
| 578 | Mesothelioma |
| 579 | Chest X-Ray: Cavitating Lung Lesion |
| 580 | Fitness to Fly |
| 581 | Flow Volume Loop |
| 582 | Altitude Related Disorders |
| 583 | Pneumothorax: Features |
| 584 | Chest Drain |
| 585 | Hereditary Haemorrhagic Telangiectasia |
| 586 | Summary (Respiratory Medicine) |
| 587 | Oesophagus |
|---|---|
| 588 | Dysphagia |
| 589 | Pharyngeal Pouch |
| 590 | Achalasia |
| 591 | GORD: Investigation |
| 592 | Eosinophilic Oesophagitis |
| 593 | Barrett’s Oesophagus |
| 594 | Proton Pump Inhibitors |
| 595 | Oesophageal Cancer |
| 596 | Oesophageal Disorders |
| 597 | Stomach |
| 598 | Dyspepsia |
| 599 | Drugs Causing Dyspepsia |
| 600 | Helicobacter Pylori: Tests |
| 601 | Helicobacter Pylori |
| 602 | Zollinger-Ellison Syndrome |
| 603 | Gastric Cancer |
| 604 | SB (Small Bowel) |
| 605 | Acute Upper Gastrointestinal Bleeding |
| 606 | Oesophageal Varices |
| 607 | Upper Gastrointestinal Bleeding |
| 608 | Hepatorenal Syndrome: Management |
| 609 | IBS (Irritable Bowel Syndrome: Diagnosis) |
| 610 | IBS |
| 611 | Malabsorption |
| 612 | Jejunal Villous Atrophy |
| 613 | Coeliac Disease |
| 614 | Bile-Acid Malabsorption |
| 615 | Gastric MALT Lymphoma |
| 616 | Coeliac Disease: Investigation |
| 617 | Coeliac Disease: Management |
| 618 | Small Bowel Bacterial Overgrowth Syndrome |
| 619 | Vitamin B12 Deficiency |
| 620 | Pernicious anaemia |
| 621 | Melanosis Coli |
| 622 | Bacterial Overgrowth: Investigation |
| 623 | Whipple’s Disease |
| 624 | Carcinoid Syndrome |
| 625 | LB (Large Bowel) |
| 626 | Inflammatory Bowel Disease: Key Difference |
| 627 | Ulcerative Colitis |
| 628 | Ulcerative Colitis: Flares |
| 629 | Ulcerative Colitis: Colorectal Cancer |
| 630 | IBD: Histology |
| 631 | Aminosalicylate Drugs |
| 632 | Crohn’s disease |
| 633 | Crohn’s Disease: Investigation |
| 634 | Crohn’s Disease: Management |
| 635 | Ulcerative Colitis: Management |
| 636 | Cholangiocarcinoma |
| 637 | Acute Appendicitis |
| 638 | Colorectal Cancer: Referral Guidelines |
| 639 | Colorectal Cancer: Screening |
| 640 | Anal Cancer |
| 641 | VIPoma |
| 642 | Enteral Feeding |
| 643 | Malnutrition |
| 644 | Laxatives |
| 645 | Villous Adenoma |
| 646 | Anal Fissure |
| 647 | Liver |
| 648 | Coagulopathy of Liver Disease |
| 649 | Dubin-Johnson Syndrome |
| 650 | Gilbert’s Syndrome |
| 651 | Hepatomegaly |
| 652 | Hepatosplenomegaly |
| 653 | Ascites |
| 654 | Child-Pugh Classification of Liver Cirrhosis |
| 655 | Hepatic Encephalopathy |
| 656 | Liver Cirrhosis |
| 657 | Spontaneous Bacterial Peritonitis |
| 658 | Alcoholic Liver Disease |
| 659 | NAFLD (Non-Alcoholic Fatty Liver Disease) |
| 660 | Budd-Chiari Syndrome |
| 661 | ALF (Acute Liver Failure) |
| 662 | HH (Haemochromatosis: Investigation) |
| 663 | Haemochromatosis: Features |
| 664 | WD (Wilson’s Disease) |
| 665 | Primary Biliary Cholangitis Features |
| 666 | Primary Biliary Cirrhosis |
| 667 | Gallstones |
| 668 | Cholangitis |
| 669 | Intrahepatic Cholestasis of Pregnancy |
| 670 | Ascending Cholangitis |
| 671 | HIV: Biliary and Pancreatic Disease |
| 672 | AIH (Autoimmune Hepatitis) |
| 673 | PSC (Primary Sclerosing Cholangitis) |
| 674 | Ischaemic Hepatitis |
| 675 | Post-Cholecystectomy Syndrome |
| 676 | Hepatitis B |
| 677 | Hepatitis B and Pregnancy |
| 678 | Hepatitis B Serology |
| 679 | Hepatitis C |
| 680 | Hepatitis D |
| 681 | Hepatocellular Carcinoma |
| 682 | Liver Biopsy |
| 683 | Pancreas |
| 684 | Acute Pancreatitis |
| 685 | AP (Acute Pancreatitis: Causes) |
| 686 | Acute Pancreatitis: Complications |
| 687 | CP (Chronic Pancreatitis) |
| 688 | Acute Mesenteric Ischaemia |
| 689 | Management of Pancreatitis |
| 690 | Pancreatic Cancer |
| 691 | Mesenteric Ischaemia |
| 692 | Colorectal Cancer: Genetics |
| 693 | Peutz-Jeghers Syndrome |
| 694 | AJCCC Staging of Colorectal Cancer |
| 695 | Pancreatic Cancer: Features |
| 696 | Ischaemia to Lower Gastrointestinal Tract |
| 697 | Total Parenteral Nutrition |
| 698 | Summary (GIT & Hepatology) |
| 699 | Syphilis |
|---|---|
| 700 | Syphilis: Investigation |
| 701 | Syphilis: Management |
| 702 | Leptospirosis |
| 703 | Lyme Disease: Features |
| 704 | Lyme Disease |
| 705 | Listeria |
| 706 | Rickettsiae |
| 707 | Typhus |
| 708 | Q fever |
| 709 | Gastroenteritis: Causes |
| 710 | Escherichia Coli |
| 711 | Cholera |
| 712 | Enteric Fever |
| 713 | Shigella |
| 714 | Campylobacter |
| 715 | Amoebiasis |
| 716 | Enteroviruses |
| 717 | Norovirus |
| 718 | Tetanus |
| 719 | Tetanus: Vaccination |
| 720 | Botulism |
| 721 | Clostridium Difficile |
| 722 | Cat Scratch Disease |
| 723 | STI: Ulcers |
| 724 | Lymphogranuloma Venereum |
| 725 | Chlamydia |
| 726 | Gonorrhoea |
| 727 | Non-Gonococcal Urethritis |
| 728 | Pelvic Inflammatory Disease |
| 729 | Epididymo-Orchitis |
| 730 | Vaginal Discharge |
| 731 | Trichomonas Vaginalis |
| 732 | Bacterial Vaginosis |
| 733 | Genital Herpes |
| 734 | Pubic Lice |
| 735 | Urinary Tract Infection in Adults: Management |
| 736 | Helminths |
| 737 | Nematodes |
| 738 | Strongyloides Stercoralis |
| 739 | Tape Worms |
| 740 | Schistosomiasis |
| 741 | Wuchereria Bancrofti |
| 742 | Trypanosomiasis |
| 743 | Malaria: Falciparum |
| 744 | Malaria: Non-Falciparum |
| 745 | Malaria: Investigation |
| 746 | Malaria: Prophylaxis |
| 747 | Leishmaniasis |
| 748 | Giardiasis |
| 749 | Toxoplasmosis |
| 750 | Cryptosporidiosis |
| 751 | HIV: The Virus |
| 752 | HIV: Seroconversion |
| 753 | HIV: Testing |
| 754 | Infectious Mononucleosis |
| 755 | HIV: Opportunistic Infections & Other Disorder |
| 756 | HIV: Diarrhea |
| 757 | HIV: Kaposi’s Sarcoma |
| 758 | HIV: Biliary and Pancreatic Disease |
| 759 | HIV: Mycobacterium Avium Complex |
| 760 | HIV and Pregnancy |
| 761 | HIV: Immunization |
| 762 | HIV: Neurocomplications |
| 763 | HIV: immunology |
| 764 | HIV: Management |
| 765 | Immune Reconstitution Inflammatory Syndrom |
| 766 | Herpes Simplex Virus |
| 767 | Herpes Simplex Encephalitis |
| 768 | HN Influenza Pandemic |
| 769 | Epstein-Barr Virus: Associated Conditions |
| 770 | Hepatitis E |
| 771 | Cytomegalovirus |
| 772 | Viral Haemorrhagic Fevers |
| 773 | Dengue Fever |
| 774 | Chikungunya |
| 775 | Measles |
| 776 | Zika Virus |
| 777 | Yellow fever |
| 778 | Antibiotics: Mechanisms of Action |
| 779 | Virulence Factors |
| 780 | Antibiotic Guidelines |
| 781 | Antibiotics: Bactericidal vs. Bacteriostatic |
| 782 | Antibiotics: Gross Mechanism of Action |
| 783 | Antibiotics: Protein Synthesis Inhibitors |
| 784 | Cephalosporins |
| 785 | Tetracyclines |
| 786 | Trimethoprim |
| 787 | Vancomycin |
| 788 | Linezolid |
| 789 | Antiviral Agents |
| 790 | HIV: Anti-Retrovirals |
| 791 | Antifungal Agents |
| 792 | Post-Exposure Prophylaxis |
| 793 | Vaccinations |
| 794 | BCG Vaccine |
| 795 | Chickenpox |
| 796 | Chickenpox Exposure in Pregnancy |
| 797 | Rabies |
| 798 | Orf |
| 799 | Parvovirus B |
| 800 | Classification of Bacteria |
| 801 | Identifying Gram-Positive Bacteria |
| 802 | Staphylococci |
| 803 | MRSA |
| 804 | Staphylococcal Toxic Shock Syndrome |
| 805 | Sepsis |
| 806 | Streptococci |
| 807 | Anthrax |
| 808 | Brucellosis |
| 809 | Tuberculosis: Drug Therapy |
| 810 | Tuberculosis: Features |
| 811 | Tuberculosis: Drug Side-Effects and Mechanism |
| 812 | Tuberculosis: Screening |
| 813 | Mycobacterium Marinum |
| 814 | Leprosy |
| 815 | Melioidosis |
| 816 | Meningitis: Causes |
| 817 | Meningitis: CSF Analysis |
| 818 | Meningococcal Septicaemia: Investigations |
| 819 | Meningitis: Management |
| 820 | Cerebrospinal Fluid |
| 821 | Acute Epiglottitis |
| 822 | Diphtheria |
| 823 | Animal and Human Bites |
| 824 | Cellulitis |
| 825 | Pyogenic Liver Abscess |
| 826 | Necrotising Fasciitis |
| 827 | Osteomyelitis |
| 828 | Splenectomy & Vaccinations |
| 829 | Post-Splenectomy Sepsis |
| 830 | Congenital Infections |
| 831 | Pyrexia of Unknown Origin |
| 832 | Haematological Malignancies: Infections |
| 833 | Otitis externa |
| 834 | Exotoxins and endotoxins |
| 835 | Human Papilloma Virus Vaccination |
| 836 | Diseases & Treatments |
| 837 | Diseases & Investigations |
| 838 | Summary (Infectious Diseases) |
| SL | Clinical Pharmacology |
|---|---|
| 839 | Pharmacology |
| 840 | P Enzyme System |
| 841 | P Drug Interactions: More Detail |
| 842 | Isoniazid Inhibits the P System |
| 843 | Genetic Polyrnorphisms of Drug Metabolism |
| 844 | Pregnancy and Drug Therapies |
| 845 | Teratogens |
| 846 | Epilepsy: Pregnancy and Breast Feeding |
| 847 | Prescribing in Pregnant Patients |
| 848 | Breast Feeding: Contraindications |
| 849 | Therapeutic Drug Monitoring |
| 850 | GPD Deficiency |
| 851 | SJW (St John’s Wort) |
| 852 | Drugs Which Act on Serotonin Receptors |
| 853 | Drugs Causing Photosensitivity |
| 854 | Drug Causes of Urticarial |
| 855 | Drugs Causing Ocular Problems |
| 856 | IGT |
| 857 | Drug-Induced Liver Disease |
| 858 | Drug-Induced Pancytopaenia |
| 859 | Drug-Induced Thrombocytopenia |
| 860 | Drug Causes of Agranulocytosis |
| 861 | Lithium |
| 862 | Lithium Toxicity |
| 863 | Digoxin and Digoxin Toxicity |
| 864 | ECG: Digoxin |
| 865 | Theophylline |
| 866 | Quinine Toxicity (Cinchonism) |
| 867 | COP (Carbon Monoxide Poisoning) |
| 868 | Methanol Poisoning |
| 869 | EGT (Ethylene Glycol Toxicity) |
| 870 | Salicylate Overdose |
| 871 | Haemodialysis in Overdose |
| 872 | Tricyclic Overdose |
| 873 | PARA-OD |
| 874 | Paracetamol Overdose: Risk Factors |
| 875 | Paracetamol Overdose: Management |
| 876 | Alcohol Withdrawal |
| 877 | Cocaine |
| 878 | Ecstasy Poisoning |
| 879 | Lead Poisoning |
| 880 | Acute Intermittent Porphyria: Drugs |
| 881 | Mercury Poisoning |
| 882 | Cyanide Poisoning |
| 883 | Antiarrhythmics |
| 884 | Amiodarone |
| 885 | AIH (Amiodarone and The Thyroid Gland) |
| 886 | Cytotoxic Agents |
| 887 | Azathioprine |
| 888 | Ciclosporin |
| 889 | Tacrolimus |
| 890 | Phenytoin |
| 891 | Sodium Valproate |
| 892 | Over Dose |
| 893 | Overdose and Poisoning: Management |
| 894 | Organophosphate Insecticide Poisoning |
| 895 | Alcohol – Problem Drinking: Management |
| 896 | Beta-Blocker Overdose |
| 897 | Benzodiazepines |
| 898 | Caustic Substance Ingestion |
| 899 | CVS |
| 900 | Drugs Acting on Common Receptors |
| 901 | Adrenoceptors |
| 902 | Aspirin |
| 903 | Clopidogrel |
| 904 | Dipyridamole |
| 905 | Lipid Lowering Drugs |
| 906 | Statins |
| 907 | Nicotinic Acid |
| 908 | Adrenoceptor Agonists |
| 909 | Adrenoceptor Antagonists |
| 910 | Beta-Blockers |
| 911 | Adrenaline |
| 912 | Angiotensin-Converting Enzyme Inhibitors |
| 913 | Calcium Channel Blockers |
| 914 | Loop Diuretics |
| 915 | Bendroflumethiazide |
| 916 | Thiazide Diuretics |
| 917 | Potassium-Sparing Diuretics |
| 918 | Spironolactone |
| 919 | Hypomagnesaemia |
| 920 | Long QT Syndrome |
| 921 | Adenosine |
| 922 | Hydralazine |
| 923 | Atropine |
| 924 | Flecainide |
| 925 | Warfarin |
| 926 | Warfarin Management of High INR |
| 927 | Heparin |
| 928 | Side-Effects of Common Drugs: Anti-Anginals |
| 929 | Sildenafil – Phosphodiesterase type V inhibitors |
| 930 | Prescribing in Patients with Heart Failure |
| 931 | Rheumatology |
| 932 | Methotrexate |
| 933 | Steroid Doses |
| 934 | Allopurinol Inhibits Xanthine Oxidase |
| 935 | Bisphosphonates |
| 936 | Tamoxifen |
| 937 | Hormone Replacement Therapy: Adverse Effects |
| 938 | Hormone Replacement Therapy: Indications |
| 939 | Endocrinology |
| 940 | Octreotide |
| 941 | Combined Oral Contraceptive Pill: Adv/Disadv |
| 942 | Oral Contraceptive Pill: Contraindications |
| 943 | Oral Contraceptive Pill: Special Situations |
| 944 | Progestogen Only Pill: Adv/Disadv |
| 945 | Gynaecomastia |
| 946 | Metformin |
| 947 | Side-Effects of Diabetes Drugs |
| 948 | Nephrology |
| 949 | Prescribing in Patients with Renal Failure |
| 950 | Urology |
| 951 | Benign Prostatic Hyperplasia |
| 952 | Finasteride |
| 953 | Drug-Induced Urinary Retention |
| 954 | Hematology |
| 955 | Gingival Hyperplasia |
| 956 | Trastuzumab |
| 957 | Cyclophosphamide |
| 958 | Immunoglobulins: Therapeutics |
| 959 | Monoclonal Antibodies |
| 960 | Dermatology |
| 961 | Isotretinoin |
| 962 | DRESS Syndrome |
| 963 | Neurology |
| 964 | Antipsychotics |
| 965 | Monoamine Oxidase Inhibitors |
| 966 | Dopamine Receptor Agonists |
| 967 | Oculogyric Crisis |
| 968 | Serotonin Syndrome |
| 969 | Infectious Diseases |
| 970 | Antibiotics: Gross Mechanism Of Action |
| 971 | Macrolides |
| 972 | Penicillin Allergy |
| 973 | Gentamicin |
| 974 | Tuberculosis: Drug Side-Effects |
| 975 | Peri & Post of Pharmacology |
| 976 | Anaesthetic Agents |
| 977 | Muscle Relaxants |
| 978 | Local Anaesthetic Agents |
| 979 | Post Operative Fluid Management |
| 980 | Others |
| 981 | Pharmacokinetics: Excretion |
| 982 | Pharmacokinetics: Metabolism |
| 983 | Anaphylaxis |
| 984 | -HT Antagonists |
| 985 | Antihistamines |
| 986 | Botulinum Toxin |
| 987 | Motion Sickness |
| 988 | Proton Pump Inhibitors |
| 989 | Smoking Cessation |
| 990 | Novel Psychoactive Substances |
| 991 | Summary (Cli Pharmacology & Toxicology) |
| 992 | Anatomy |
|---|---|
| 993 | Carpal Tunnel Syndrome |
| 994 | Cranial Nerves |
| 995 | Upper Limb Anatomy |
| 996 | Ulnar Nerve |
| 997 | Radial Nerve |
| 998 | Brachial Plexus |
| 999 | Dermatomes |
| 1000 | Common Peroneal Nerve Lesion |
| 1001 | Brain Tumours |
| 1002 | Spinal Cord |
| 1003 | Temporal Artery Biopsy |
| 1004 | Adrenal Medulla |
| 1005 | Cell Organelles |
| 1006 | Coronary Circulation |
| 1007 | Transposition of the Great Arteries |
| 1008 | Epidermis |
| 1009 | Facial Nerve |
| 1010 | Foramina of the Skull |
| 1011 | Renal Anatomy |
| 1012 | Popliteal Fossa |
| 1013 | Physiology |
| 1014 | Adrenoceptors |
| 1015 | Antidiuretic Hormone |
| 1016 | Atrial Natriuretic Peptide |
| 1017 | Natriuretic Peptide |
| 1018 | Cell Cycle |
| 1019 | Cell Division |
| 1020 | Microtubules |
| 1021 | Endothelin |
| 1022 | Membrane Receptors |
| 1023 | Nitric Oxide |
| 1024 | P53 |
| 1025 | Renin |
| 1026 | Renin-Angiotensin-Aldosterone System |
| 1027 | Muscle Contraction |
| 1028 | Second Messengers |
| 1029 | Cardiac Enzymes and Protein Markers |
| 1030 | Cardiovascular Physiology |
| 1031 | Troponin |
| 1032 | Obesity: Physiology |
| 1033 | Cardiac Action Potential |
| 1034 | Valsalva Manoeuvre |
| 1035 | Oxygen Dissociation Curve |
| 1036 | Pulmonary Surfactant |
| 1037 | Respiratory Physiology: Control |
| 1038 | Respiratory Physiology: Lung Volumes |
| 1039 | Respiratory Physiology: Hypoxia |
| 1040 | Cerebral Perfusion Pressure |
| 1041 | Respiratory Physiology: Lung Compliance |
| 1042 | Respiratory Physiology |
| 1043 | Renal Physiology |
| 1044 | Erythropoiesis |
| 1045 | Food Energy |
| 1046 | Gastrointestinal Hormones |
| 1047 | Gastrointestinal Physiology: Enzymes |
| 1048 | Growth Hormone |
| 1049 | Menstrual Cycle |
| 1050 | Prolactin |
| 1051 | Sleep Stages |
| 1052 | Ferritin |
| 1053 | Biochemistry |
| 1054 | Hyponatraemia |
| 1055 | Hyponatraemia: Correction |
| 1056 | SIADH: Causes |
| 1057 | Hyperkalaemia |
| 1058 | Hypokalaemia |
| 1059 | Hypokalaemia and Hypertension |
| 1060 | Pseudohyperkalaemia |
| 1061 | Hypokalaemia and Acid-Base Balance |
| 1062 | Hyperkalaemia Management |
| 1063 | Metabolic Acidosis |
| 1064 | Respiratory Acidosis |
| 1065 | Metabolic Alkalosis |
| 1066 | Respiratory Alkalosis |
| 1067 | Parathyroid Glands & Disorders |
| 1068 | Calcium Metabolism |
| 1069 | Calcium Homeostasis |
| 1070 | Alkaline Phosphatase |
| 1071 | Hypercalcaemia: Causes |
| 1072 | Hypercalcaemia: Management |
| 1073 | Anion Gap |
| 1074 | ECG: Hypokalaemia |
| 1075 | Fluid Therapy |
| 1076 | Post-Operative Fluid Management |
| 1077 | Hypocalcaemia: Causes and Management |
| 1078 | Hypocalcaemia: Features |
| 1079 | Hypomagnesaemia |
| 1080 | Hypercalcaemia: Features |
| 1081 | Refeeding Syndrome |
| 1082 | Hypophosphataemia |
| 1083 | Hyperlipidaemia Management |
| 1084 | Hyperlipidaemia Secondary Causes |
| 1085 | Acute Phase Proteins |
| 1086 | Energy from Food |
| 1087 | Erythrocyte Sedimentation Rate (ESR) |
| 1088 | Folate Metabolism |
| 1089 | Iron Metabolism |
| 1090 | Urinary Casts |
| 1091 | Pathology |
| 1092 | Oncogenes |
| 1093 | Osteomalacia |
| 1094 | Collagen |
| 1095 | Vitamin D-Resistant Rickets |
| 1096 | Clubbing |
| 1097 | Macroglossia |
| 1098 | Porphyrias |
| 1099 | Acute Intermittent Porphyria |
| 1100 | Alkaptonuria |
| 1101 | Cystinuria |
| 1102 | Atherosclerosis |
| 1103 | Familial Hypercholesterolaemia |
| 1104 | Inherited Metabolic Disorders |
| 1105 | Galactosaemia |
| 1106 | Anderson-Fabry Disease |
| 1107 | Fabry Disease |
| 1108 | Hyperuricaemia |
| 1109 | Pellagra |
| 1110 | Phenylketonuria |
| 1111 | Vitamin B1 (Thiamine) |
| 1112 | Vitamin B2 (Riboflavin) |
| 1113 | Vitamin B3 (Niacin) |
| 1114 | Vitamin B6 (Pyridoxine) |
| 1115 | Vitamin C Deficiency (Scurvy) |
| 1116 | Vitamin D Supplementation |
| 1117 | Vitamin D |
| 1118 | Vitamin B12 Deficiency |
| 1119 | Vitamin C (Ascorbic Acid) |
| 1120 | Vitamin K |
| 1121 | Vitamin Deficiency |
| 1122 | Zinc Deficiency |
| 1123 | Reye’s Syndrome |
| 1124 | Cardiac Imaging |
| 1125 | Positron Emission Tomography (PET) |
| 1126 | Trauma Management |
| 1127 | Immunology |
| 1128 | Adaptive Immune Response |
| 1129 | Complement Deficiencies |
| 1130 | Hereditary Angioedema |
| 1131 | HLA Associations |
| 1132 | HLA Typing and Graft Failure |
| 1133 | Hypersensitivity |
| 1134 | Latex Allergy |
| 1135 | Anaphylaxis |
| 1136 | Allergy Tests |
| 1137 | Innate Immune Response |
| 1138 | T-Helper Cells |
| 1139 | Immunoglobulins |
| 1140 | Immunoglobulins Therapeutics |
| 1141 | Monoclonal Antibodies |
| 1142 | Primary Immunodeficiency |
| 1143 | Digeorge Syndrome |
| 1144 | Wiskott-Aldrich Syndrome |
| 1145 | Ataxic Telangiectasia |
| 1146 | Cytokines |
| 1147 | IL-1 |
| 1148 | Tumour Necrosis Factor |
| 1149 | Interferon |
| 1150 | Leukotrienes |
| 1151 | Molecular Biology Techniques |
| 1152 | Polymerase Chain Reaction (PCR) |
| 1153 | Genetics |
| 1154 | Autosomal Dominant |
| 1155 | X-Linked Recessive |
| 1156 | Mitochondrial Diseases |
| 1157 | Autosomal Dominant Conditions |
| 1158 | Autosomal Recessive Conditions |
| 1159 | X-Linked Recessive Conditions |
| 1160 | X-Linked Dominant |
| 1161 | Autosomal Recessive |
| 1162 | Penetrance and Expressivity |
| 1163 | Downs Syndrome: Features |
| 1164 | Down’s Syndrome: Epidemiology and Genetics |
| 1165 | Alpha Thalassaemia |
| 1166 | Fragile X Syndrome |
| 1167 | Human Genome |
| 1168 | William’s Syndrome |
| 1169 | Kallman’s Syndrome |
| 1170 | Klinefelter’s Syndrome |
| 1171 | Noonan Syndrome |
| 1172 | Prader-Willi Syndrome |
| 1173 | Trinucleotide Repeat Disorders |
| 1174 | Tumour Suppressor Genes |
| 1175 | Turner’s Syndrome |
| 1176 | Achondroplasia |
| 1177 | Paraneoplastic Syndromes |
| 1178 | Wilms’ Tumour |
| 1179 | Marfan’s Syndrome |
| 1180 | Homocystinuria |
| 1181 | Cell Surface Proteins |
| 1182 | Abg Interpretation & Practice |
| 1183 | Miscellaneous |
| 1184 | Fitness to Fly |
| 1185 | Patients Who Refuse Treatment |
| 1186 | Statistics |
| 1187 | ND (Normal Distribution) |
| 1188 | SD (Standard Deviation) |
| 1189 | SkD (Skewed Distributions) |
| 1190 | Confidence Interval & SEM |
| 1191 | Variance |
| 1192 | Correlation |
| 1193 | Correlation and Linear Regression |
| 1194 | Funnel Plot |
| 1195 | Hazard Ratio |
| 1196 | Bias |
| 1197 | Clinical Audit |
| 1198 | Screening Test Statistics |
| 1199 | Screening: Wilson and Junger Criteria |
| 1200 | Concept of EER & CER |
| 1201 | Relative Risk |
| 1202 | Relative Risk Reduction (RRR) |
| 1203 | Absolute Risk Reduction |
| 1204 | Number Needed to Treat (NNT) |
| 1205 | Odds and Odds Ratio |
| 1206 | Incidence and Prevalence |
| 1207 | Pre-test & Post-test Probability & Odds |
| 1208 | Significance Tests |
| 1209 | Clinical trial: phases |
| 1210 | Study Design: Evidence and Recommendations |
| 1211 | Study Design: New Drugs |
| 1212 | Types of Study |
| 1213 | Intention to Treat Analysis |
| 1214 | Summary (Clinical Sciences) |
| SL | Content |
|---|---|
| 1215 | GD- (Glomerulonephritides) |
| 1216 | Glomerulonephritis and Low Complement |
| 1217 | IgA Nephropathy |
| 1218 | HSP (Henoch-Schonlein Purpura) |
| 1219 | SLE: Renal Complications |
| 1220 | MCD (Minimal Change Disease) |
| 1221 | MGN (Membranous Glomerulonephritis) |
| 1222 | Membranoproliferative Glomerulonephritis |
| 1223 | FSGS (Focal Segmental Glomerulosclerosis) |
| 1224 | HIV: Renal Involvement |
| 1225 | Rapidly Progressive Glomerulonephritis |
| 1226 | GPS (Goodpasture’s Syndrome) |
| 1227 | Wegener’s Granulomatosis |
| 1228 | NOS (Nephrotic Syndrome) |
| 1229 | Nephrotic Syndrome: Causes |
| 1230 | Nephrotic Syndrome: Complications |
| 1231 | Amyloidosis types |
| 1232 | Amyloidosis |
| 1233 | Acute Kidney Injury (AKI) |
| 1234 | Acute Kidney Injury: A Very Basic Introduction |
| 1235 | Acute Kidney Injury: Nice Guidelines |
| 1236 | Acute tubular necrosis |
| 1237 | Acute Tubular Necrosis Vs. Prerenal Uraemia |
| 1238 | Acute interstitial nephritis |
| 1239 | CKD (Chronic Kidney Disease: Causes) |
| 1240 | Chronic Kidney Disease: eGFR and Classification |
| 1241 | Chronic Kidney Disease: Anaemia |
| 1242 | CKD: Bone Disease Management |
| 1243 | Chronic Kidney Disease: Bone Disease |
| 1244 | Chronic Kidney Disease: Proteinuria |
| 1245 | DN (Diabetic Nephropathy: Stages) |
| 1246 | Erythropoietin |
| 1247 | Chronic Kidney Disease: Hypertension |
| 1248 | RTA (Renal Vascular Disease) |
| 1249 | Fibromuscular dysplasia |
| 1250 | Retroperitoneal Fibrosis |
| 1251 | Renal Tubular Acidosis |
| 1252 | Fanconi Syndrome |
| 1253 | Reflux nephropathy |
| 1254 | CE (Cholesterol Embolization) |
| 1255 | Nephrotoxicity Due to Contrast Media |
| 1256 | RM (Rhabdomyolysis) |
| 1257 | Haemolytic uraemic syndrome |
| 1258 | Alport’s Syndrome |
| 1259 | Goodpasture’s syndrome |
| 1260 | Thin Basement Membrane Disease |
| 1261 | ADPKD |
| 1262 | ADPKD: Features |
| 1263 | ARPKD |
| 1264 | Renal Stones: Risk Factors |
| 1265 | Renal Stones: Types |
| 1266 | Renal Stones: Management |
| 1267 | Cystinuria |
| 1268 | Fluid therapy |
| 1269 | Renal Cell Cancer |
| 1270 | Prescribing in Patients with Renal Failure |
| 1271 | Wilms’ Tumour |
| 1272 | Papillary Necrosis |
| 1273 | Xanthogranulomatous pyelonephritis |
| 1274 | Plasma Exchange |
| 1275 | Sterile Pyuria |
| 1276 | Haematuria |
| 1277 | Polyuria |
| 1278 | Diabetes insipidus |
| 1279 | Peritoneal Dialysis |
| 1280 | Arteriovenous Fistulas |
| 1281 | Complications Following Renal Transplant |
| 1282 | Urinary Incontinence |
| 1283 | Benign Prostatic Hyperplasia |
| 1284 | Bladder Cancer: Risk Factors |
| 1285 | Lower Urinary Tract Symptoms In Men |
| 1286 | Epididymo-orchitis |
| 1287 | Testicular cancer |
| 1288 | Prostate Cancer: PSA Testing |
| 1289 | Prostate cancer: management |
| 1290 | Renal Transplant: Immunosuppression |
| 1291 | Summary (Renal Medicine) |
| 1292 | Blood Films: Pathological Cell Forms |
|---|---|
| 1293 | Blood Films: Typical Pictures |
| 1294 | Schistocytes |
| 1295 | Hyposplenism |
| 1296 | Anaemia |
| 1297 | Types of Anaemia |
| 1298 | Macrocytic Anaemia |
| 1299 | Vitamin B Deficiency |
| 1300 | Iron-Deficiency Anaemia (IDA) |
| 1301 | Beta-Thalassaemia Major |
| 1302 | Beta-Thalassemia Trait |
| 1303 | Alpha-Thalassaemia |
| 1304 | Sideroblastic Anaemia |
| 1305 | Lead Poisoning |
| 1306 | Porphyrias |
| 1307 | Acute Intermittent Porphyria |
| 1308 | An Approach to Haemolytic Anaemia |
| 1309 | Causes of Haemolytic Anaemia |
| 1310 | Autoimmune Haemolytic Anaemia |
| 1311 | Haemolytic Anaemias: By Site |
| 1312 | Hereditary Spherocytosis |
| 1313 | GPD Deficiency |
| 1314 | Sickle-Cell Anaemia |
| 1315 | Sickle-Cell Crises |
| 1316 | Sickle-Cell Anaemia: Management |
| 1317 | Paroxysmal Nocturnal Haemoglobinuria |
| 1318 | Methaemoglobinaemia |
| 1319 | Laboratory Findings in Haematological Disease |
| 1320 | Leucocyte Alkaline Phosphatase |
| 1321 | Leukaemoid Reaction |
| 1322 | Haematological Malignancies: Genetics |
| 1323 | Haematological Malignancies: Infections |
| 1324 | Chronic Myeloid Leukaemia |
| 1325 | Myelofibrosis |
| 1326 | Polycythaemia |
| 1327 | Polycythaemia Vera: Features |
| 1328 | Polycythaemia Vera: Management |
| 1329 | Acute Myeloid Leukaemia |
| 1330 | Acute Promyelocytic Leukaemia |
| 1331 | Neutropaenia |
| 1332 | Lymphadenopathy |
| 1333 | Acute Lymphoblastic Leukaemia |
| 1334 | Chronic Lymphocytic Leukaemia: Factors |
| 1335 | Chronic Lymphocytic Leukaemia |
| 1336 | Chronic Lymphocytic Leukaemia: Management |
| 1337 | Hairy Cell Leukaemia |
| 1338 | Thrombocytopenia |
| 1339 | Immune Thrombocytopenic Purpura (ITP) |
| 1340 | Immune Thrombocytopenia (ITP) in Adults |
| 1341 | Thrombotic Thrombocytopenic Purpura |
| 1342 | Haemolytic Uraemic Syndrome |
| 1343 | Von Willebrand’s Disease |
| 1344 | Wiskott-Aldrich Syndrome |
| 1345 | Hereditary Haemorrhagic Telangiectasia |
| 1346 | Antiphospholipid Syndrome |
| 1347 | Antiphospholipid Syndrome: Pregnancy |
| 1348 | Paraproteinaemia |
| 1349 | Myeloma: Features |
| 1350 | Myeloma: Prognosis |
| 1351 | Complications of Myeloma |
| 1352 | Waldenstrom’s Macroglobulinaemia |
| 1353 | MGUS |
| 1354 | Primary Immunodeficiency |
| 1355 | Venous Thromboembolism: Risk Factors |
| 1356 | Thrombophilia: Causes |
| 1357 | Deep Vein Thrombosis: Diagnosis & Management |
| 1358 | Antithrombin III Deficiency |
| 1359 | Pregnancy: DVT/PE |
| 1360 | Pregnancy: DVT/PE Investigation |
| 1361 | Protein C Deficiency |
| 1362 | Disseminated Intravascular Coagulation |
| 1363 | Disseminated Intravascular Coagulation |
| 1364 | Aplastic Anaemia: Management |
| 1365 | Drug-Induced Pancytopaenia |
| 1366 | Prostate Cancer: Features |
| 1367 | Prostate Cancer: Management |
| 1368 | Hodgkin’s Lymphoma: Staging |
| 1369 | Hodgkin’s Lymphoma: Histological Classification |
| 1370 | Non-Hodgkin’s Lymphoma |
| 1371 | Haemophilia |
| 1372 | Thrombocytosis |
| 1373 | Activated Protein C Resistance |
| 1374 | Factor V Leiden |
| 1375 | Eosinophilia |
| 1376 | Anaphylaxis |
| 1377 | Oral Allergy Syndrome |
| 1378 | Allergy Tests |
| 1379 | Hereditary Angioedema |
| 1380 | Latex Allergy |
| 1381 | Bladder Cancer: Risk Factors |
| 1382 | Thymoma |
| 1383 | Neoplastic Spinal Cord Compression |
| 1384 | Cytotoxic Agents |
| 1385 | Cyclophosphamide |
| 1386 | Anti-Oestrogen Drugs |
| 1387 | Chemotherapy Side-Effects: Nausea and Vomiting |
| 1388 | Blood Product Transfusion Complications |
| 1389 | CMV Negative and Irradiated Blood |
| 1390 | FFP, Cryoprecipitate and Prothrombin Complex |
| 1391 | Platelet Transfusion: Active Bleeding |
| 1392 | Burkitt’s Lymphoma |
| 1393 | Cancer in The UK |
| 1394 | Cervical Cancer |
| 1395 | Human Papilloma Virus Infection |
| 1396 | Heparin |
| 1397 | Warfarin |
| 1398 | Warfarin Overdose |
| 1399 | Monoclonal Antibodies |
| 1400 | Neutropenic Sepsis |
| 1401 | Granulocyte-Colony Stimulating Factors |
| 1402 | Palliative Care Prescribing: Pain |
| 1403 | Palliative Care Prescribing: Agitation and Confusion |
| 1404 | Palliative Care Prescribing: Hiccups |
| 1405 | Superior Vena Cava Obstruction |
| 1406 | Tumour Lysis Syndrome |
| 1407 | Amyloidosis: Types |
| 1408 | Genetics and Surgical Disease |
| 1409 | Tumour Markers |
| 1410 | Positron Emission Tomography (PET) |
| 1411 | Bronchial Carcinoma |
| 1412 | Lung Cancer: Non-Small Cell |
| 1413 | Carcinogens |
| 1414 | Bone Metastases |
| 1415 | Carcinogens |
| 1416 | ECOG Score |
| 1417 | Prostate Cancer: Management |
| 1418 | Spinal Metastases |
| 1419 | IgG-related Disease |
| 1420 | Summary (Haematology & Oncology) |
| SL | Content |
|---|---|
| 1421 | Depression vs. Dementia |
| 1422 | Dementia |
| 1423 | Alzheimers Disease |
| 1424 | Normal Pressure Hydrocephalus |
| 1425 | Schizophrenia: Prognostic Indicators |
| 1426 | Schizophrenia: Epidemiology |
| 1427 | Schizophrenia: Management |
| 1428 | Schizophrenia: Features |
| 1429 | Delusional parasitosis |
| 1430 | Atypical Antipsychotics |
| 1431 | Lithium |
| 1432 | Antipsychotics |
| 1433 | Neuroleptic Malignant Syndrome |
| 1434 | Depression: Screening and Assessment |
| 1435 | Depression in Older People |
| 1436 | Serotonin & noradrenaline reuptake inhibitors |
| 1437 | SSRI (Selective Serotonin Reuptake Inhibitors) |
| 1438 | Serotonin syndrome |
| 1439 | Generalised anxiety disorder and panic disorder |
| 1440 | Tricyclic Antidepressants |
| 1441 | Anorexia Nervosa |
| 1442 | Anorexia Nervosa: Features |
| 1443 | Bulimia Nervosa |
| 1444 | OCD (Obsessive-compulsive disorder) |
| 1445 | Hypomania vs. Mania |
| 1446 | Unexplained Symptoms |
| 1447 | Acute Confusional State |
| 1448 | Suicide |
| 1449 | Suicide: Risk Factors |
| 1450 | Cognitive Behavioural Therapy |
| 1451 | Seasonal Affective Disorder |
| 1452 | Alcohol Withdrawal |
| 1453 | Aphonia |
| 1454 | Benzodiazepines |
| 1455 | Body Dysmorphic Disorder |
| 1456 | Electroconvulsive Therapy |
| 1457 | Grief Reaction |
| 1458 | Post-Concussion Syndrome |
| 1459 | Post-Partum Mental Health Problems |
| 1460 | Post-Traumatic Stress Disorder |
| 1461 | Sleep Paralysis |
| 1462 | Agoraphobia |
| 1463 | Charles-Bonnet Syndrome |
| 1464 | Cotard Syndrome |
| 1465 | De Clerambault’s Syndrome |
| 1466 | Korsakoff’s Syndrome |
| 1467 | Monoamine Oxidase Inhibitors |
| 1468 | Othello’s Syndrome |
| 1469 | Personality Disorders |
| 1470 | Post-Concussion Syndrome |
| 1471 | Summary (Psychiatry) |
| SL | Content |
|---|---|
| 1472 | Diabetic Retinopathy |
| 1473 | Vitreous Haemorrhage |
| 1474 | Central retinal artery occlusion |
| 1475 | Sudden Loss of Vision |
| 1476 | Optic Atrophy |
| 1477 | Optic Neuritis |
| 1478 | Relative Afferent Pupillary Defect |
| 1479 | Angioid Retinal Streaks |
| 1480 | Acute Angle Closure Glaucoma |
| 1481 | Retinitis Pigmentosa |
| 1482 | Red Eye |
| 1483 | Lacrimal Duct Problems |
| 1484 | Cataracts |
| 1485 | Tunnel Vision |
| 1486 | Blepharitis |
| 1487 | Herpes Zoster Ophthalmicus |
| 1488 | Age Related Macular Degeneration |
| 1489 | Herpes Simplex Keratitis |
| 1490 | Holmes-Adie Pupil |
| 1491 | Mydriasis |
| 1492 | Primary Open-Angle Glaucoma |
| 1493 | Primary Open-Angle Glaucoma-Management |
| 1494 | Visual Field Defects |
| 1495 | Miosis |
| 1496 | Hypertensive Retinopathy |
| 1497 | Horner’s Syndrome |
| 1498 | Rheumatoid Arthritis: Ocular Manifestations |
| 1499 | Keratitis |
| 1500 | Vitamin A Toxicity |
| 1501 | Papilloedema |
| 1502 | Central retinal vein occlusion |
| 1503 | Orbital cellulitis |
| 1504 | Posterior vitreous detachment |
| 1505 | Summary (Medical Ophthalmology) |
SsAcademy will provide you with all the necessary study materials for exam preparation. You won’t need to purchase any other study materials.
SsAcademy offer you an Advacned Revision Course along with Your Regular Course for Exam Practice. This Advacned Revision couse is based on the Mock Exam with all updated Questions. SsAcademy charge a nominal price for this mock test series.
SsAcademy provides you two sets of Question Banks. Which are Pasttest & OnExam. SsAcademy only charge for Printing Cost of this Question Bank. Here printing cost is 5,500 BDT for OnExam and 6,500 BDt for Pastest.
If you somehow miss to attend any classes then SsAcademy will arrage a recorded video for you. You can watch the reocrded video online.
SsAcademy will help you in MRCP Exam Application. Not only that the full team of SsAcademy will be ready to help you in any ways till your final exam. Your sucess is our desination.
MRCP, MRCS, MRCOG & MRCPCH
You can get admission directly by coming to the office. In that case, our address is: 30 Green Road (1st Floor), Dhaka-1205
[Every day we are open from 10:00 A.M to 6:00 P.M, except for Saturday ]
Or, you can confirm your admission by sending money through the bank or bKash, informing us.
Attending classes on campus or via (Zoom) online, both are available. You can choose any medium at your convenience. (There may be area-specific variations)
Yes, After enrolling in the course, you can directly discuss study topics or guidelines with your mentor in the Telegram group or during class.
If you admit to any regular course, you will get the lecture notes in book form. Besides, you can buy a specific question bank from us separately, for practice. Except for this, you do not need to buy or subscribe to any other study materials.
Please follow the below payment procedure to complete your admission. After payment completion, please send your money receipt or reference number via SMS/WhatsApp. You will be admitted immediately.
The Best Lecture Materials are the most important things of success in MRCP. Sir is the best mentor I have ever seen. Simple tips & tricks, note taking is very helpful for quick rivision before exam. Sir is one of the best mentor in Medicine World.
Fatema Hossain Anannya
Dhaka Medical College Hospital
The lectures’ Notes are so organized that someone can easily take preparation for MRCP. I did both part 1 & part 2 online classes. I also did ADR. I did an exam here before my main exam which help me a lot. Sir’s lectures are so good & easily understandable.
Dr. Rowja Siddika Khan
Rajshahi Medical College
The number of tips helped me reach my goal of completing part 1. The Ss-Box helped me cover such as huge syllabus in such a short time. I definitely recommend the MRCP Course at SsAcademy for all future candidates. Best Academy For MRCP Preparation.
Dr. Khan MD Ali Arif
Hebei Medical University (China)
